Correlation of Reduction in MRP-1/CD9 and KAI1/CD82 Expression with Recurrences in Breast Cancer Patients
Open Access
- 1 September 1998
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 153 (3) , 973-983
- https://doi.org/10.1016/s0002-9440(10)65639-8
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology (07557253, 08407040)
This publication has 39 references indexed in Scilit:
- CD9, CD63, CD81, and CD82 are components of a surface tetraspan network connected to HLA‐DR and VLA integrinsEuropean Journal of Immunology, 1996
- TP53 andMYC gene alterations independently predict poor prognosis in breast cancer patientsGenes, Chromosomes and Cancer, 1996
- Association of TM4SF proteins with integrins: relevance to cancerBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1996
- Suppression of human melanoma cell growth and metastasis by the melanoma‐associated antigen CD63 (ME491)International Journal of Cancer, 1995
- Oncogene Protein Co-Expression Value of Ha-ras, c-myc, c-fos, and p53 as Prognostic Discriminants for Breast CarcinomaAnnals of Surgery, 1995
- KAI1 , a Metastasis Suppressor Gene for Prostate Cancer on Human Chromosome 11p11.2Science, 1995
- Prognostic value of c-erbB2 overexpression in axillary lymph node positive breast cancer. Results from a randomized adjuvant treatment protocolCancer, 1994
- The ins and outs of the transmembrane 4 superfamilyImmunology Today, 1994
- A new superfamily of lymphoid and melanoma cell proteins with extensive homology to Schistosoma mansoni antigen Sm23European Journal of Immunology, 1991
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958